Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease
Clinical trial NCT01015300 · TERMINATED
Trial details
- NCT number
- NCT01015300
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2011-10-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.